1. Home
  2. WEYS vs TRDA Comparison

WEYS vs TRDA Comparison

Compare WEYS & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEYS
  • TRDA
  • Stock Information
  • Founded
  • WEYS 1906
  • TRDA 2016
  • Country
  • WEYS United States
  • TRDA United States
  • Employees
  • WEYS N/A
  • TRDA 183
  • Industry
  • WEYS Apparel
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEYS Consumer Staples
  • TRDA Health Care
  • Exchange
  • WEYS Nasdaq
  • TRDA Nasdaq
  • Market Cap
  • WEYS 341.7M
  • TRDA 292.2M
  • IPO Year
  • WEYS N/A
  • TRDA 2021
  • Fundamental
  • Price
  • WEYS $31.70
  • TRDA $8.24
  • Analyst Decision
  • WEYS
  • TRDA Strong Buy
  • Analyst Count
  • WEYS 0
  • TRDA 3
  • Target Price
  • WEYS N/A
  • TRDA $25.67
  • AVG Volume (30 Days)
  • WEYS 17.2K
  • TRDA 148.2K
  • Earning Date
  • WEYS 05-06-2025
  • TRDA 05-08-2025
  • Dividend Yield
  • WEYS 9.50%
  • TRDA N/A
  • EPS Growth
  • WEYS N/A
  • TRDA N/A
  • EPS
  • WEYS 3.04
  • TRDA 0.61
  • Revenue
  • WEYS $286,762,000.00
  • TRDA $172,220,000.00
  • Revenue This Year
  • WEYS N/A
  • TRDA N/A
  • Revenue Next Year
  • WEYS N/A
  • TRDA N/A
  • P/E Ratio
  • WEYS $10.42
  • TRDA $13.70
  • Revenue Growth
  • WEYS N/A
  • TRDA 5.74
  • 52 Week Low
  • WEYS $25.51
  • TRDA $7.10
  • 52 Week High
  • WEYS $41.05
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • WEYS 52.63
  • TRDA 50.16
  • Support Level
  • WEYS $30.97
  • TRDA $7.55
  • Resistance Level
  • WEYS $32.10
  • TRDA $8.05
  • Average True Range (ATR)
  • WEYS 1.10
  • TRDA 0.40
  • MACD
  • WEYS -0.14
  • TRDA 0.05
  • Stochastic Oscillator
  • WEYS 28.57
  • TRDA 61.65

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: